TNF Pharmaceuticals, Inc.

(NASDAQ) QCLS

Current Price$4.33

Market Cap$34.01M

Since IPO (2021)-100%

5 Year-100%

1 Year-78%

1 Month+6%

TNF Pharmaceuticals, Inc. Financials at a Glance

Market Cap

$34.01M

Revenue (TTM)

$0.00

Net Income (TTM)

$11.75M

EPS (TTM)

$-21.21

P/E Ratio

-0.08

Dividend

$0.00

Beta (Volatility)

1.25 (Average)

Dividend

$0.00

Beta (Volatility)

1.25 (Average)

Price

$4.33

Volume

6,860

Open

$4.78

Price

$4.33

Volume

6,860

Open

$4.78

Previous Close

$4.33

Daily Range

$4.28 - $4.90

52-Week Range

$2.50 - $33.56

Dividend

$0.00

Beta (Volatility)

1.25 (Average)

Price

$4.33

Volume

6,860

Open

$4.78

Previous Close

$4.33

Daily Range

$4.28 - $4.90

52-Week Range

$2.50 - $33.56

QCLS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About TNF Pharmaceuticals, Inc.

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Christopher C. Chapman, Jr., MD

Website

www.qctechnologies.com

Headquarters

New York, NY 10036, US

QCLS Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-63%

Return on Capital

-27%

Return on Assets

-31%

Earnings Yield

-12.50%

Dividend Yield

0.00%

Payout Ratio

-1.15%

Stock Overview

Market Cap

$34.01M

Shares Outstanding

7.85M

Volume

6.86K

Avg. Volume

649.83K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$9.85M

EBITDA

$9.85M

Operating Cash Flow

$9.07M

Capital Expenditure

$2.01M

Free Cash Flow

$11.07M

Cash & ST Invst.

$15.79M

Total Debt

$0.00

TNF Pharmaceuticals, Inc. Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$34.01M

N/A

Market Cap/Employee

$5.67M

N/A

Employees

N/A

Net Income

$1.24M

-10.5%

EBITDA

$1.86M

+24.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$12.97M

+120.8%

Accounts Receivable

$16.80K

+576.9%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-30.67%

N/A

Return on Invested Capital

-26.68%

N/A

Free Cash Flow

$3.29M

-24.5%

Operating Cash Flow

$3.29M

-24.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

HPAIHelport AI Limited

HPAIHelport AI Limited$1.15-10.16%

APCXAppTech Payments Corp.

APCXAppTech Payments Corp.$0.37+2.78%

GITSGlobal Interactive Technologies, Inc.

GITSGlobal Interactive Technologies, Inc.$1.36-3.55%

JTAIJet.AI Inc.

JTAIJet.AI Inc.$6.96+1.75%

OBLGOblong, Inc.

OBLGOblong, Inc.$1.56-4.29%

JDZGJIADE Limited

JDZGJIADE Limited$2.21+32.34%

RIMEAlgorhythm Holdings, Inc.

RIMEAlgorhythm Holdings, Inc.$0.66-8.19%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

POETPoet Technologies

POETPoet Technologies$15.97-0.22%

INTCIntel

INTCIntel$108.77-0.06%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.98+0.05%

NOKNokia

NOKNokia$13.95-0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

ONDSOndas

ONDSOndas$10.62-0.05%

Questions About QCLS

What is the current price of TNF Pharmaceuticals, Inc.?

TNF Pharmaceuticals, Inc. is trading at $4.33 per share.

What is the 52-week range for TNF Pharmaceuticals, Inc.?

Over the past 52 weeks, TNF Pharmaceuticals, Inc. has traded between $2.50 and $33.56.

How much debt does TNF Pharmaceuticals, Inc. have?

As of the most recent reporting period, TNF Pharmaceuticals, Inc. reported total debt of N/A.

How much cash does TNF Pharmaceuticals, Inc. have on hand?

TNF Pharmaceuticals, Inc. reported $1.13M in cash and cash equivalents in its most recent financial results.

What is TNF Pharmaceuticals, Inc.’s dividend yield?

TNF Pharmaceuticals, Inc. does not currently have a dividend yield.

TNF Pharmaceuticals, Inc.

TNF Pharmaceuticals, Inc. Financials at a Glance

QCLS News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About TNF Pharmaceuticals, Inc.

QCLS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

TNF Pharmaceuticals, Inc. Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About QCLS

What is the current price of TNF Pharmaceuticals, Inc.?

What is the 52-week range for TNF Pharmaceuticals, Inc.?

How much debt does TNF Pharmaceuticals, Inc. have?

How much cash does TNF Pharmaceuticals, Inc. have on hand?

What is TNF Pharmaceuticals, Inc.’s dividend yield?

Premium Investing Services